Simplex Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-147
Closed -$242K 8699
2020
Q2
$242K Hold
147
﹤0.01% 3786
2020
Q1
$124K Buy
147
+58
+65% +$811 ﹤0.01% 4138
2019
Q4
$201K Buy
89
+13
+17% +$185 ﹤0.01% 3751
2019
Q3
$109K Buy
+76
New +$1.11K ﹤0.01% 4239
2019
Q1
Sell
-1
Closed -$1K 8032
2018
Q4
$1K Sell
1
-17
-94% -$299 ﹤0.01% 6813
2018
Q3
$38K Buy
+18
New +$547 ﹤0.01% 5435
2018
Q2
Sell
-8
Closed -$22K 7997
2018
Q1
$22K Sell
8
-4
-33% -$283 ﹤0.01% 3275
2017
Q4
$9K Sell
12
-130
-92% -$10.8K ﹤0.01% 4026
2017
Q3
$202K Buy
142
+138
+3,450% +$10.6K 0.01% 1183
2017
Q2
$2K Sell
4
-14
-78% -$1.73K ﹤0.01% 5382
2017
Q1
$13K Buy
18
+16
+800% +$2.29K ﹤0.01% 3740
2016
Q4
$9K Sell
2
-9
-82% -$1.01K ﹤0.01% 3870
2016
Q3
$70K Hold
11
﹤0.01% 1826
2016
Q2
$87K Sell
11
-16
-59% -$1.98K 0.01% 1585
2016
Q1
$183K Buy
27
+15
+125% +$3.04K 0.01% 924
2015
Q4
$37K Buy
12
+1
+9% +$326 ﹤0.01% 2163
2015
Q3
$62K Sell
11
-25
-69% -$11K ﹤0.01% 1820
2015
Q2
$34K Sell
36
-11
-23% -$4.67K ﹤0.01% 1987
2015
Q1
$71K Buy
47
+8
+21% +$3.1K 0.01% 1314
2014
Q4
$78K Buy
+39
New +$11.6K 0.01% 1078

Other funds holding LUMO

Simplex Trading's LUMO Position: Q4 2019 in Review

Simplex Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 3,002 shares — an estimated $42.8K sold.

Simplex Trading first reported a position in LUMO in Q4 2014 and held it in 10 quarters. The position peaked at $1.54M in Q1 2017. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Simplex Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 3,002 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $42.8K.
  • Simplex Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lumos Pharma, Inc. Common Stock position peaked at $1.54M in Q1 2017.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.